Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria-Reference-Cited by-同舟云学术

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS‐PSP Criteria

Published:2020-08-21 Issue:11 Volume:35 Page:2009-2018
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord

Author:

Martí‐Andrés Gloria¹²^ORCID,Bommel Liza³,Meles Sanne K.³,Riverol Mario¹²,Valentí Rafael¹²,Kogan Rosalie V.⁴^ORCID,Renken Remco J.⁵,Gurvits Vita⁴,Laar Teus³^ORCID,Pagani Marco⁶,Prieto Elena⁷,Luquin M. Rosario¹²,Leenders Klaus L.³⁴,Arbizu Javier²⁸

Affiliation:

1. Department of Neurology Clínica Universidad de Navarra, University of Navarra Pamplona Spain

2. IdiSNA (Navarra Institute for Health Research) Pamplona Spain

3. Department of Neurology University Medical Center Groningen Groningen the Netherlands

4. Department of Nuclear Medicine and Molecular Imaging University Medical Center Groningen Groningen the Netherlands

5. NeuroImaging Center University Medical Center Groningen Groningen the Netherlands

6. Institute of Cognitive Sciences and Technologies, CNR Rome Italy

7. Department of Medical Physics Clínica Universidad de Navarra Pamplona Spain

8. Department of Nuclear Medicine and Molecular Imaging Clínica Universidad de Navarra, University of Navarra Pamplona Spain

Funder

Stichting ParkinsonFonds

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.28217

Reference54 articles.

1. The phenotypic spectrum of progressive supranuclear palsy: A retrospective multicenter study of 100 definite cases

2. Which ante mortem clinical features predict progressive supranuclear palsy pathology?

3. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism

4. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome

5. Clinical diagnosis of progressive supranuclear palsy: The movement disorder society criteria

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuroenergetic alterations in neurodegenerative diseases: A systematic review and meta-analysis of in vivo 31P-MRS studies;Ageing Research Reviews;2024-09

2. Accuracy of 18F-FDG PET Imaging in Differentiating Parkinson's Disease from Atypical Parkinsonian Syndromes: A Systematic Review and Meta-Analysis;Academic Radiology;2024-08

3. Radiomics-Guided Deep Learning Networks Classify Differential Diagnosis of Parkinsonism;Brain Sciences;2024-07-04

4. Levodopa modulates semantic fluency and uniqueness in non‐demented patients with progressive supranuclear palsy;Brain and Behavior;2024-06-30

5. Frontal hypometabolism in the diagnosis of progressive supranuclear palsy clinical variants;Journal of Neurology;2024-04-17